News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
ASCO25 Liquid Biopsy Highlights – International Society of Liquid Biopsy
ISLB/islb.info
Aug 20, 2025, 15:55

ASCO25 Liquid Biopsy Highlights – International Society of Liquid Biopsy

International Society of Liquid Biopsy shared a post on X about a recent article by Shivahamy Maheswaran et al. published in The Journal of Liquid Biopsy:

“ASCO25 Liquid Biopsy Highlights

Liquid biopsy is entering clinical practice

  • Plasma-guided chemo in NSCLC
  • ctDNA-driven therapy switch in HR+/HER2− BC
  • ctDNA-negativity → less axillary surgery?
  • Post-op ctDNA = strong prognostic tool in CRC and MIBC
  • Multi-omics and Pap-derived cfDNA → future of early detection and risk stratification

But challenges remain: assay heterogeneity, discordant results, and standardization needs.
Full editorial from ISLB Young Committee in The Journal of Liquid Biopsy.”

Title: Cancer in a Drop: Liquid biopsy insights from AACR 2025

Authors: Shivahamy Maheswaran, Roberto Borea, Diego de Miguel Perez, Pasquale Pisapia, Nadia Ghazali, Canio Martinelli, Pavel Stejskal, Carolina Reduzzi

Read the Full Article on The Journal of Liquid Biopsy.

ASCO25 Liquid Biopsy Highlights - International Society of Liquid Biopsy

More posts featuring International Society of Liquid Biopsy on OncoDaily.

cancer Canio Martinelli Carolina Reduzzi Diego de Miguel Perez International Society of Liquid Biopsy Nadia Ghazali OncoDaily Oncology Pasquale Pisapia Pavel Stejskal Roberto Borea Shivahamy Maheswaran The Journal of Liquid Biopsy
Special Coverage
Science
Aug 20, 2025, 15:55
ASCO25 Liquid Biopsy Highlights - International Society of Liquid Biopsy
Voices
Aug 20, 2025, 15:54
Chrystal Paulos Has Been Awarded V Foundation All-Star Grant - Winship Cancer Institute of Emory University
Voices
Aug 20, 2025, 15:52
Kirsten Efremov: Strengthening Patient Engagement in the Adolescent and Young Adult Cancer Community
Insight
Aug 20, 2025, 15:42
Joshua Palmer: Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy
Immune Oncology
Aug 20, 2025, 15:42
New IO Paper Alert: Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for First-Line Immunotherapy Outcomes in HCC.
Voices
Aug 20, 2025, 15:41
Rob Winn: The NIH's 15% Indirect Cost Cap - A Misunderstanding of Research Reality
Opinion
Aug 20, 2025, 15:36
Elisabeth Potter: The Impact of Rising Insurance Costs on Breast Cancer Treatment Choices
Voices
Aug 20, 2025, 15:32
Minhua Chu: BNT327 (Pumitamig) Shows Promising Efficacy in ES-SCLC in Phase II Trial
Dialogues
Aug 20, 2025, 15:27
How Can We Accelerate New Drug Development for Children with Cancer? | Second Global Oncothon
Voices
Aug 20, 2025, 15:24
The Role of Radiotherapy and AI in Cancer Treatment at National Summit - National Cancer Institute of Kenya
Dialogues
Aug 20, 2025, 15:22
How Can We Better Manage GI Side Effects from New Cancer Therapies? | MASCC 2025
Insight
Aug 20, 2025, 15:20
Jame Abraham Thanks Nathan Pennell for Leadership at Cleveland Clinic